查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1739315

全球自動藥品亭市場

Automated Drug Kiosks
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 164 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年，全球自動藥品亭市場規模將達到 273 億美元

全球自動販賣機亭市場規模預計在2024年為116億美元，預計到2030年將達到273億美元，2024年至2030年的複合年成長率為15.3%。自動售藥亭系統是本報告分析的細分市場之一，預計其複合年成長率為17.1%，到分析期結束時規模將達到196億美元。自動售藥亭服務細分市場在分析期間的複合年成長率預計為11.5%。

美國市場規模估計為 31 億美元，中國市場預計複合年成長率為 14.3%

美國自動化藥品亭市場規模預計在2024年達到31億美元。作為世界第二大經濟體，中國市場規模預計到2030年將達到42億美元，在2024-2030年的分析期間內，複合年成長率為14.3%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為14.4%和13.0%。在歐洲，預計德國市場的複合年成長率為11.0%。

全球自動藥品亭市場－主要趨勢與促進因素摘要

自動藥品亭為何成為無障礙藥局的可擴展解決方案

自動販賣機提供了一種安全的自助服務方式，可以取代傳統的藥局櫃檯，從而徹底改變人們的藥品取得方式。這些自助售藥亭可在醫院、診所、機場和偏遠地區全天候提供處方藥和非處方藥。這簡化了「最後一公里」的藥品配送，同時解決了藥劑師短缺和等待時間過長的難題。這些系統旨在透過電子核准和身份驗證來發放預包裝藥品，從而提高患者便利性，同時確保合規性和存取管理。

醫療保健提供者和零售藥局擴大部署這些自助服務終端，以擴大其覆蓋範圍，而無需承擔擴張實體店的全部營運成本。隨著遠端保健的普及，自助服務終端正成為連接虛擬問診和實體藥物管理的關鍵接觸點。與電子健康記錄(EHR) 系統整合，可實現無縫的照護現場，提高用藥依從性，並減少治療開始的延誤。

科技創新如何讓藥局亭更加安全、合規和整合？

現代自動售藥亭配備了先進的安全通訊協定、生物識別和即時監控，以確保安全合規的配藥。與藥房管理軟體和雲端基礎平台整合，藥劑師可以遠端核准處方箋、追蹤庫存並管理續藥週期。此外，還新增了視訊會議模組，以保持患者與藥劑師之間的互動，並方便藥劑師按需諮詢，同時保持自助售藥亭的自主性。

篡改檢測、溫度控制和審核就緒追蹤等符合監管規定的功能，使自助服務終端成為敏感和受控藥物的合規解決方案。與保險資料庫和電子處方箋系統的整合，可直接在自助服務終端上進行資格驗證和共同支付處理。隨著與更廣泛的數位健康生態系統互通性的增強，這些自助服務終端正在發展成為智慧的分散式藥房節點，可支援門診病人和慢性病護理工作流程。

自動藥房亭的採用在哪裡加速？哪些使用案例推動了成長？

在資源受限的醫療保健系統中，尤其是在藥局資源有限的農村和服務不足地區，自助取藥機的應用正在加速。醫院和緊急護理中心正在部署自助取藥機，以便在出院後和下班後提供藥物，從而降低再入院風險並提高護理的連續性。零售連鎖藥局正在購物中心、機場和校園等人流量大的公共場所試行自助取藥機，讓病患即時取得常用藥物和保健產品。

政府醫療保健計畫和人道主義組織正在考慮部署自助服務終端，作為偏遠和低收入地區公共衛生推廣工作的一部分。此外，大型雇主和大學正在其健康中心安裝這些系統，以簡化員工健康管理。使用案例也正在擴展到懲教機構、老年生活社區和軍事基地，在這些領域，可管理、可追溯且高效的配藥至關重要。

是什麼推動了自動化藥品亭市場的全球擴張？

市場成長的驅動力源自於醫療保健消費者意識的提升、成本控制壓力以及藥房服務數位轉型的要求。患者日益要求便利、私密和全天候服務，而自助服務終端能夠以傳統配藥成本的一小部分滿足這些需求。疫情期間，人們轉向非接觸式服務模式，進一步檢驗了自動化配藥在增強醫藥服務韌性和可近性方面的作用。

連鎖藥局、醫療系統和醫療技術公司正在攜手合作，擴大部署規模，並實現與現有臨床和藥房工作流程的標準化整合。監管機構正在逐步更新其夥伴關係，以納入遠端藥房模式，鼓勵其更廣泛的接受。隨著醫療保健日益分散化和以患者為中心，一個核心問題日益凸顯：在一個致力於提高公平性、效率和服藥依從性的系統中，自動藥亭能否成為「最後一哩路」藥物配送的支柱？

部分

產品類型（系統、服務）；藥品類型（處方箋、非處方藥、其他藥品類型）；最終用途（零售藥局、醫院/診所、其他最終用途）

調查企業範例（共34家企業）

  • Asteres Inc.
  • Bell and Howell
  • BestKiosk
  • Capsa Healthcare
  • Diebold Nixdorf
  • Distributed Delivery Networks Corp.
  • Higi
  • Howell LLC
  • ImageHOLDERS
  • Jadak
  • MC HealthGrid Pvt Ltd.
  • MedAvail Technologies Inc.
  • MedfriendRx
  • Omnicell Inc.
  • PharmcoRx
  • PickPoint
  • Rowa Automatisierungssysteme GmbH
  • ScriptPro LLC
  • Smart RX Systems Inc.
  • Stericycle Inc.

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口（成品和原始OEM）來預測其競爭地位的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括人為提高銷貨成本、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

全球產業分析師密切關注來自全球頂尖首席經濟學家（14,949位）、智庫（62家）以及貿易和產業協會（171家）的專家的意見，以評估其對生態系統的影響並應對新的市場現實。我們追蹤了來自每個主要國家的專家和經濟學家對關稅及其對本國影響的看法。

全球產業分析師預計，這場動盪將在未來2-3個月內逐漸平息，新的世界秩序將更加清晰地建立。全球產業分析師正在即時追蹤這些事態發展。

2025年4月：談判階段

在4月的報告中，我們將探討關稅對全球整體市場的影響，並提供區域市場調整。我們的預測是基於歷史數據和不斷變化的市場影響因素。

2025年7月：最終關稅調整

在各國宣布最終重置後，客戶將在 7 月收到免費更新，最終更新將包含明確的關稅影響分析。

相互和雙邊貿易及關稅影響分析：

美國<>中國<>墨西哥<>加拿大<>歐盟<>日本<>印度<>其他176個國家

領先的產業經濟學家：全球產業分析師知識庫追蹤了 14,949 位經濟學家，其中包括來自民族國家、智庫、貿易和產業協會、大型企業以及各領域專家的最具影響力的首席經濟學家，他們共用了這場前所未有的全球經濟狀況模式轉移的影響。我們超過 16,491 份報告大多遵循基於里程碑的兩階段發布計劃。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 比賽

簡介目錄
Product Code: MCP33481

Global Automated Drug Kiosks Market to Reach US$27.3 Billion by 2030

The global market for Automated Drug Kiosks estimated at US$11.6 Billion in the year 2024, is expected to reach US$27.3 Billion by 2030, growing at a CAGR of 15.3% over the analysis period 2024-2030. Automated Drug Kiosk Systems, one of the segments analyzed in the report, is expected to record a 17.1% CAGR and reach US$19.6 Billion by the end of the analysis period. Growth in the Automated Drug Kiosk Services segment is estimated at 11.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.1 Billion While China is Forecast to Grow at 14.3% CAGR

The Automated Drug Kiosks market in the U.S. is estimated at US$3.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.2 Billion by the year 2030 trailing a CAGR of 14.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 14.4% and 13.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.0% CAGR.

Global Automated Drug Kiosks Market - Key Trends & Drivers Summarized

Why Are Automated Drug Kiosks Emerging as Scalable Solutions for Accessible Pharmaceutical Dispensing?

Automated drug kiosks are transforming medication access by offering secure, self-service alternatives to traditional pharmacy counters. These kiosks provide round-the-clock availability of prescription and over-the-counter drugs in hospitals, clinics, airports, and remote locations-streamlining last-mile pharmaceutical delivery while addressing pharmacist shortages and wait-time challenges. Designed to dispense pre-packaged medications via electronic authorization and identity verification, these systems enhance convenience for patients while ensuring regulatory compliance and controlled access.

Healthcare providers and retail pharmacies are increasingly deploying these kiosks to expand service reach without incurring full operational costs associated with brick-and-mortar expansions. As telehealth adoption accelerates, automated kiosks are becoming critical touchpoints that bridge virtual consultations with physical medication fulfillment. Their integration into electronic health record (EHR) systems enables seamless, point-of-care dispensing, improving medication adherence and reducing delays in treatment initiation.

How Are Technological Innovations Enhancing the Safety, Compliance, and Integration Capabilities of Drug Kiosks?

Modern automated drug kiosks are equipped with advanced safety protocols, biometric authentication, and real-time monitoring to ensure secure and compliant dispensing. Integration with pharmacy management software and cloud-based platforms allows pharmacists to remotely approve prescriptions, track inventory, and manage refill cycles. Video conferencing modules are also being added to facilitate on-demand pharmacist consultations, preserving patient-pharmacist interaction while maintaining kiosk autonomy.

Regulatory-aligned features such as tamper detection, temperature control, and audit-ready tracking are positioning kiosks as compliant solutions even for sensitive or controlled medications. Integration with insurance databases and e-prescription systems enables eligibility verification and copay processing directly at the kiosk. As interoperability with broader digital health ecosystems strengthens, these kiosks are evolving into smart, decentralized pharmacy nodes capable of supporting both outpatient and chronic care workflows.

Where Is Adoption of Automated Drug Kiosks Accelerating and What Use Cases Are Driving Growth?

Adoption is gaining momentum in healthcare systems facing resource constraints, particularly in rural and underserved areas where pharmacy access is limited. Hospitals and urgent care centers are implementing kiosks to provide post-discharge or after-hours medication access, reducing readmission risks and improving continuity of care. Retail pharmacy chains are piloting kiosks in high-traffic public spaces-such as malls, airports, and campuses-to offer instant access to common medications and wellness products.

Government healthcare programs and humanitarian organizations are exploring kiosk deployments as part of public health outreach in remote and low-income regions. Additionally, large employers and universities are adopting these systems within wellness centers to streamline workforce health management. Use cases are also expanding into correctional facilities, senior living communities, and military bases-where controlled, trackable, and efficient dispensing is essential.

What Is Fueling the Global Expansion of the Automated Drug Kiosks Market?

Market growth is being driven by rising healthcare consumerism, cost-containment pressures, and digital transformation mandates across pharmacy services. Patients increasingly demand convenience, privacy, and 24/7 access, which kiosks can deliver at a fraction of traditional dispensing costs. The pandemic-era shift toward contactless service models further validated the role of automated dispensing in enhancing resilience and accessibility in pharmaceutical care.

Pharmacy chains, health systems, and medtech companies are forming partnerships to scale deployment and standardize integration with existing clinical and pharmacy workflows. Regulatory bodies are gradually updating guidelines to accommodate remote dispensing models, encouraging broader acceptance. As healthcare becomes more decentralized and patient-centric, a core question gains urgency: Can automated drug kiosks become the backbone of last-mile medication delivery in a system striving for greater equity, efficiency, and adherence?

SCOPE OF STUDY:

The report analyzes the Automated Drug Kiosks market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Systems, Services); Drug Type (Prescriptions, Over-The-Counters, Other Drug Types); End-Use (Retail Pharmacies, Hospitals & Clinics, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 34 Featured) -

  • Asteres Inc.
  • Bell and Howell
  • BestKiosk
  • Capsa Healthcare
  • Diebold Nixdorf
  • Distributed Delivery Networks Corp.
  • Higi
  • Howell LLC
  • ImageHOLDERS
  • Jadak
  • MC HealthGrid Pvt Ltd.
  • MedAvail Technologies Inc.
  • MedfriendRx
  • Omnicell Inc.
  • PharmcoRx
  • PickPoint
  • Rowa Automatisierungssysteme GmbH
  • ScriptPro LLC
  • Smart RX Systems Inc.
  • Stericycle Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Automated Drug Kiosks - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • 24/7 Dispensing Capability Positions Automated Drug Kiosks as a Pillar of Healthcare Accessibility
    • Integration With e-Prescriptions and EMRs Streamlines Pharmacy Workflow Through Drug Kiosks
    • Retail and Rural Healthcare Expansion Drives Adoption of Automated Drug Dispensing Kiosks
    • Pandemic-Era Contactless Health Trends Accelerate Public Acceptance of Automated Drug Kiosks
    • Regulatory Support for Remote Pharmaceutical Dispensing Enhances Legitimacy of Drug Kiosks
    • Insurance and Reimbursement Integration Improves Affordability of Medications Via Drug Kiosks
    • Compact Footprint and Low Operational Costs Make Automated Drug Kiosks Attractive to Pharmacies
    • AI-Enabled Inventory Management Increases Efficiency and Reduces Stockouts in Drug Kiosks
    • Deployment in Transit Hubs and Workplaces Expands Reach of Automated Drug Kiosk Services
    • Real-Time Access to High-Demand Medications Improves Chronic Disease Adherence Rates
    • Integration With Telepharmacy Platforms Expands Scope of Services Delivered Via Drug Kiosks
    • Automated Drug Kiosks Play a Strategic Role in Decentralizing Healthcare Distribution Networks
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Automated Drug Kiosks Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Automated Drug Kiosks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Automated Drug Kiosks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Prescriptions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Prescriptions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Over-The-Counters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Over-The-Counters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other Drug Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Other Drug Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Automated Drug Kiosks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 22: USA Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 23: USA 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Canada 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • JAPAN
    • Automated Drug Kiosks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Japan 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Japan 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • CHINA
    • Automated Drug Kiosks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 40: China Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: China 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: China 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • EUROPE
    • Automated Drug Kiosks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Automated Drug Kiosks by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe 6-Year Perspective for Automated Drug Kiosks by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • FRANCE
    • Automated Drug Kiosks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 52: France Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: France 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 54: France Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: France 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • GERMANY
    • Automated Drug Kiosks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 58: Germany Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Germany 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Germany 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • ITALY
    • TABLE 64: Italy Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Italy 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Italy 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • UNITED KINGDOM
    • Automated Drug Kiosks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 70: UK Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: UK 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 72: UK Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: UK 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 76: Rest of Europe Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Rest of Europe 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Automated Drug Kiosks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 82: Asia-Pacific Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Asia-Pacific 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 88: Rest of World Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of World 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of World 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030

IV. COMPETITION